🚚 Fast Free Shipping on All Orders
5mg/5mg · Purity: ≥99% (individual components)
Select Size
A pre-combined research vial containing CJC-1295 (No DAC) and Ipamorelin for studies examining GHRH receptor and GHS-R1a receptor co-activation in in vitro models.
This blend pairs CJC-1295 (No DAC), a GHRH analogue, with Ipamorelin, a selective GHS-R1a agonist. The combination is used in research examining the downstream effects of simultaneous GHRH receptor and growth hormone secretagogue receptor activation in cell-based assays. For qualified laboratory research only.
Store lyophilized at −20 °C. Reconstitute with sterile bacteriostatic water under aseptic conditions. Use within 30 days when stored at 4 °C after reconstitution.
Handle per applicable laboratory safety protocols. This compound is for in vitro research only.
Purity: ≥99% (individual components)
Batch Number: TODO: Update
COA: Available upon request
Testing: Third-party laboratory verification
Free standard shipping on all orders. Orders dispatched within 1–2 business days in plain, discreet packaging.
All sales are final once shipped. See our Refund Policy for full details.
peptides
Ipamorelin is a selective growth hormone secretagogue pentapeptide studied for its high GHS-R1a receptor selectivity in in vitro research models.
In vitro research use only · Not for human or animal use
peptides
CJC-1295 without DAC (Drug Affinity Complex) is a modified GHRH analogue with a shorter half-life profile, studied in GH axis receptor binding research.
In vitro research use only · Not for human or animal use
peptides
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous GHRH, studied in growth hormone axis research. High-purity lyophilized compound.
In vitro research use only · Not for human or animal use